Nabla

Nabla is an Ambient Clinical AI company founded in 2018 and based in Paris, France. It has raised $120M in total funding, most recently a Series C in 2025.

Nabla builds an ambient AI assistant that generates clinical notes from conversations, deployed across 130+ healthcare organizations with a new ambition to build agentic AI for healthcare. $70M Series C June 2025. 130+ healthcare organizations. Paris-founded, now US-headquartered. Partnership with Navina for clinical intelligence integration.

Nabla's $70M Series C in 2025 and its pivot to agentic AI represents the next frontier beyond ambient scribing: AI agents that take clinical actions, not just document them.

nabla.com Ambient Clinical AI

Franceprivate

At a glance

Total raised

$120M

last round series c

Headcount

51-200

approximate · public range

Headquarters

Paris

France

Founded

2018

8 years active

Status

Private

Ambient Clinical AI

Subsector

Funding history

Total raised

$120M

Rounds tracked

Latest stage

Series C

Date	Stage	Amount	Valuation	Lead investors
Jun 17, 2025	Series C	$70M	—	HV Capital
Jan 5, 2024	Series B	$24M	$180M	Cathay Innovation

Nabla

At a glance

Funding history

In the news

Nabla names new CEO as AI scribe looks to scale

Suki Leans on Clinician-Led AI and ROI Proof Points to Advance Ambient Documentation Strategy

Leadership

Products

Nabla Copilot

Nabla Adaptive Agentic Platform

Open roles

Compare Nabla with